Impact Events
MoreDate | Lead Company | Event | Type | Approval Change | Approval Likelihood |
---|---|---|---|---|---|
6/13/25 | Swedish Orphan Biovitrum (SOBI) | Gamifant for Histiocytosis | Subscribers Only | Subscribers Only | Subscribers Only |
6/11/25 | argenx (ARGX) | Vyvgart for Sjogren's Disease | Subscribers Only | Subscribers Only | Subscribers Only |
6/11/25 | Bristol (BMY) | Sotyktu for Psoriatic Arthritis (PsA) | Subscribers Only | Subscribers Only | Subscribers Only |
6/9/25 | PolyPid (PYPD) | D-PLEX for Intra-Abdominal Infections (Antibacterial) | Subscribers Only | Subscribers Only | Subscribers Only |
6/9/25 | Merck & Co (MRK) | MK-0616 for Dyslipidemia / Hypercholesterolemia | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
MoreExpected Date Range | Lead Company | Drug | Expected Catalyst |
---|---|---|---|
04/01/2025 | Subscribers Only | Subscribers Only | Company - Divestment/Spinoff |
04/24/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
05/20/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
05/22/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
06/02/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |